Back
Biomarin Pharmaceutical Stock Price Chart
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Buy
58
BMRN
Biomarin Pharmaceutical
Last Price:
$66.29
Seasonality Move:
9.08%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Caught Trading Under Secret Name...
Find out more about the "hidden stock" here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.09 | Sell |
| 20-day SMA: | 66.01 | Sell |
| 50-day SMA: | 66.22 | Sell |
| 200-day SMA: | 78.35 | Sell |
| 8-day EMA: | 66.07 | Sell |
| 20-day EMA: | 65.98 | Sell |
| 50-day EMA: | 67.34 | Sell |
| 200-day EMA: | 76.4 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.21 | Sell |
| Chaikin Money Flow: | -28579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.97 - 66.75) | Sell |
| Bollinger Bands (100): | (63.25 - 82.77) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 65.73 while BMRN 8-day simple moving average is 66.09, which is a Sell signal.
-
The stock price of BMRN is 65.73 while Biomarin Pharmaceutical 20-day SMA is 66.01, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day simple moving average is 66.22 while BMRN share price is 65.73, making it a Sell technically.
-
BMRN stock price is 65.73 and Biomarin Pharmaceutical 200-day simple moving average is 78.35, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
58
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $65.73. The Score for BMRN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
12.5B
Price in USD:
65.73
Share Volume:
790.7K
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.25
52-Week Low:
61.15
Buy
58
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 65.73 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 65.73 while BMRN 8-day exponential moving average is 66.07, which is a Sell signal.
-
The stock price of BMRN is 65.73 while Biomarin Pharmaceutical 20-day EMA is 65.98, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day exponential moving average is 67.34 while BMRN share price is 65.73, making it a Sell technically.
-
BMRN stock price is 65.73 and Biomarin Pharmaceutical 200-day simple moving average is 76.40, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $0.99 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Biomarin Pharmaceutical is a Sell
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 48.21, which suggest Biomarin Pharmaceutical is oversold
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (64.97 - 66.75), which suggest Biomarin Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (63.25 - 82.77), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.